NCT04921657View on ClinicalTrials.gov

Genome-wide Analysis of Lipid-lowering Efficacy and Drug Level of Simvastatin and Rosuvastatin

CompletedOBSERVATIONAL
Enrollment

362

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Hypercholesterolemia
Interventions
DRUG

Rosuvastatin 10mg

Trial Locations (1)

Unknown

Brian Tomlinson, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT04921657 - Genome-wide Analysis of Lipid-lowering Efficacy and Drug Level of Simvastatin and Rosuvastatin | Biotech Hunter | Biotech Hunter